ukall60 : identifying the standard of care for elderly patients with all
Published 7 years ago • 78 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:21
the challenges associated with treating elderly patients with all
-
5:40
final results from the ukall60 trial
-
3:07
how age as a prognostic factor affects treatment options for all
-
0:52
tocilizumab for aa amyloidosis
-
1:59
providing novel treatments and standardising cll biomarker testing across the world
-
1:23
management of high-risk newly diagnosed mm
-
1:15
key themes at eha 2020
-
2:12
social media – a useful tool for hematological research
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:56
novel drugs for myeloma thromboprophylaxis
-
0:51
nelarabine as first-line treatment for t-cell all: facing the problem up-front
-
3:09
treatment strategies for chl patients after auto-hsct
-
1:11
making clinical decisions with patients
-
2:12
treatment choice for mm in uk practice
-
2:42
optimizing biological agents for all
-
1:21
andromeda study: updated safety run-in results
-
4:16
novel therapies for mpns